* Nkarta Inc NKTX.OQ reported a quarterly adjusted loss
of 58
cents per share for the quarter ended in January, higher than
the same quarter last year, when the company reported EPS of -63
cents. The mean expectation of seven analysts for the quarter
was for a loss of 56 cents per share. Wall Street expected
results to range from -65 cents to -46 cents per share.
* Reported revenue was zero; analysts expected zero.
* Nkarta Inc's reported EPS for the quarter was a loss of 58
cents.
* The company reported a quarterly loss of $29.52 million.
* Nkarta Inc shares had fallen by 40.8% this quarter and
lost 3.0%
so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 7.7%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"
Wall Street's median 12-month price target for Nkarta Inc is
$18.00
This summary was machine generated from LSEG data May 9 at 09:58
p.m. UTC. All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 -0.56 -0.58 Missed
Dec. 31 2023 -0.59 -0.57 Beat
Sep. 30 2023 -0.67 -0.52 Beat
Jun. 30 2023 -0.68 -0.60 Beat